Skip to content
Screener

Ashland ASH Life Sciences — Operating Income

Other segment segments

Unallocated And Other
-$37M+24.5%
Personal Care And Household
$29M+16.0%
Intermediates And Solvents
$3M-25.0%
Specialty Additives
$3M+101%

Similar metrics at other companies

Ecolab logo
ECLGlobal Life Sciences — Operating Income
$58.5M+45.5%
RCM Technologies logo
RCMTLife Sciences Data Solutions — Operating Income
$2.05M-3.7%
TEC
TECHProtein Sciences — Operating Income
$100M-3.8%
WAT
WATWaters Analytical And Materials Sciences — Operating Income
$236M+9.8%
U-Haul Holding logo
UHALLife Insurance — Operating Income
$3.59M+34.3%
Verb Technology Company, Inc. logo
TONXMarket Live — Operating Income
-$273K+55.9%

Other financials

Income statement

See full
Revenue$497.0M+7.3%
Gross profit$170.0M+28.8%
Operating income$43.0M+106%
Net income$16.0M+102%
EPS (diluted)$0.35+102%

Balance sheet

See full
Cash & equivalents$440.0M+113%
Total debt$1.5B-0.6%
Total equity$1.9B-1.0%
Total assets$4.6B-0.9%

Cash flow

See full
Operating cash flow$120.0M+4.3%
CapEx$20.0M0.0%
Free cash flow$100.0M+5.3%

Valuation

See full
Market cap$3.32B+40.6%
Enterprise value$4.35B+19.7%
P/E165.9×
P/S1.8×+0.5×

Profitability

See full
Gross margin31.5%+1.4pp
Operating margin4.1%
Net margin1.1%+0.5pp
FCF margin13.6%+9.7pp

Returns & leverage

See full
Return on equity1.1%+0.5pp
Debt / equity0.8×0.0×
Current ratio+0.4×

Where this comes from

Reported directly by Ashland in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Ashland’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 5:17 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-324226
(In millions - unaudited)Three months ended / June 30 / 2026Three months ended / June 30 / 2025Nine months ended / June 30 / 2026Nine months ended / June 30 / 2025
Unallocated and other(1)(3)165
$(1)$706$(3)$871
Operating income (loss)
Life Sciences$45$(343)$97$(301)
Personal Care29256764
Specialty Additives3(345)(12)(343)
Intermediates3466
Total operating segments80(659)158(574)

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Ashland's life sciences — operating income?
Ashland (ASH) reported life sciences — operating income of $45M in Q2 2026.
How has Ashland's life sciences — operating income changed year-over-year?
Ashland's life sciences — operating income increased by 113.1% year-over-year, from -$343M to $45M.
What is the long-term trend for Ashland's life sciences — operating income?
Over 3 years (2021 to 2024), Ashland's life sciences — operating income has grown at a 8.9% compound annual growth rate (CAGR), from $130M to $168M.
What does life sciences — operating income mean?
This represents the profit or loss generated by the Life Sciences segment after deducting operating expenses such as cost of goods sold, research and development, and selling, general, and administrative costs. It serves as a primary indicator of the segment's core operational efficiency and business health. It excludes interest, taxes, and non-operating items to isolate business-level performance.

Ask your AI about Ashland's life sciences — operating income.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude